Jeff Salzman Email & Phone Number

United States

St Louis, Missouri, United States

Ann Arbor, Michigan, United States

Parsippany, NJ

• Responsible for strategy development and execution of private payer coverage for Interpace Diagnostics’ oncology testing portfolio, including ThyGeNEXT+ThyraMIR and PancraGEN
• Negotiated 17 new BCBS/health plan agreements within the first year of joining the company
• Obtained positive coverage from eviCore (laboratory benefit management company)
• Developed and executed PLA coding strategy for ThyraMIR (thyroid miRNA classifier)
• Held Payer Advisory Board to gain support from health plan medical directors
• Developed billing and coding strategies for new and re-launched oncologic assays

San Francisco Bay Area

• Company lead for all things related to coverage, coding, pricing, and billing of AlloMap and AlloSure, assays used to monitor the organ health of transplant patients.
• Led the effort for obtaining coverage for AlloSure Kidney and AlloSure Heart with the Molecular Diagnostics Program (MolDX) of Palmetto GBA and the private payer community
• Managed the composition of the AlloSure Kidney pricing dossier, resulting in Medicare reimbursement of $2,840
• Oversaw the data collection, review, and submission of private payer reimbursement data for AlloMap to comply with the Protecting Access to Medicare Act of 2014 (PAMA), resulting in a 14% price increase (2017)
• Successfully defended AlloMap’s Medicare rate during “crosswalk/gapfill” negotiations with CMS (2016)
• Met with members of congress and staffers to influence the outcome of laboratory-related issues (e.g. Date of Service, PAMA concerns, etc.)

Washington D.C. Metro Area

• Accountable for all strategic and tactical pre-launch activities related to obtaining coverage and reimbursement for TruGraf, a blood-based method for distinguishing between rejection and other causes of renal.
• Led the company through the process of becoming a participating Medicare provider with Noridian Healthcare Services
• Navigated Transplant Genomics through the Palmetto MolDx program, including obtaining a McKesson “Z-code” for TruGraf, “pre-submission” meeting, and technical assessment for Medicare coverage
• Developed billing policies, templates for appeals, and other materials related to reimbursement from patients and payors

Washington D.C. Metro Area

Independent consultant for clinical laboratories/diagnostic companies and IVD manufacturers specializing in health policy, coverage, and reimbursement with public and private payors. Examples of assignments include educating several genetic testing companies with understanding/mapping the "path to coverage" and recommendations to reach this goal.

South San Francisco, CA

• Responsible for the strategic and tactical design and execution of programs leading to expanding coverage (public and private) for the PLAC Test for Lp-PLA2, cleared by the FDA to aid in assessing risk for both.
• Expanded ICD-9 coverage in two high-value Medicare jurisdictions (Palmetto GBA and Novitas Solutions) leading to millions of dollars of previously unrecognized revenue; recipient of the diaDexus “Trailblazer” award as.
• Designed and implemented a multifaceted campaign to retain Medicare coverage in Noridian Jurisdiction E and restore coverage in Jurisdiction F
• Testified before CMS (July, 2014) regarding inconsistencies in Medicare coverage nationwide and the potential impact of the Protecting Access to Medicare Act of 2014 (PAMA)
• Designed and implemented a formal payer appeals program to expand coverage and increase the average sales price of the PLAC Test
• Worked with CMS to enforce statutory coverage of the PLAC Test with Medicare Advantage plans

Austin, Texas

Provided guidance and strategic direction for obtaining third party coverage and reimbursement for Vermillion’s “OVA1,” a diagnostic assay utilized for the malignancy evaluation of an ovarian mass. Defined, developed, and executed policy coverage and revenue management strategies with Quest Diagnostics, Vermillion’s commercialization partner.

Stamford, CT

Responsible for critical prelaunch activities associated with IPSOGEN's North American breast cancer division for a laboratory-developed predictive molecular genomic assay. IPSOGEN (France) decided not to move forward with the North American launch resulting in the layoff of the entire U.S.-based management team.

South San Francisco, CA

Developed and executed field-based payer strategies for Monogram Biosciences’ HIV and Oncology franchises, including obtaining coverage policies and reimbursement with national (Aetna, United Healthcare) and regional payers (Virginia through New England). Represented the HERmark Breast Cancer Assay to medical oncologists, breast surgeons, and pathologists.

Madison, NJ

Returned to Quest Diagnostics (having previously worked with Quest from 1997 - 2005) to direct nationwide marketing initiatives for the Health Plan segment, incorporating finance, sales, research, advertising, promotion, and new product launches. Provided strategic direction and guidance for executing marketing plans to achieve revenue growth from the.

Adjunct professor for Brenau University’s Evening and Weekend Online College. Taught Small Business Management and Marketing Principals to class sizes averaging 14 students. Responsible for curriculum, web site design, student assessment, and evaluation.

South Florida

Originally SmithKline Beecham Clinical Laboratories, then acquired by Quest Diagnostics, performed sales and marketing of Clinical Laboratory and Healthcare Services to payers in Florida and Alabama. Accountable for identifying and targeting new clients while expanding existing base through strong relationships with all levels of management. Negotiated.

South Florida; Atlanta, GA; Horsham, PA

Manager of Provider Relations for Prudential’s preferred and managed medical and dental insurance products for the Eastern region of the United States. Directed 25 field Network Managers servicing over 3,500 participating dental providers. Developed and implemented network expansion campaigns and strategies for recruitment of new dental offices. Consulted.

Directed a 12,000 member wholly owned staff model HMO/PPO primary and urgent care facility, Humana’s largest in Florida. Accountable for managing medical center’s $24 million budget and preparation of financial summary reports. Experienced gained in all areas of medical center operations, network development, reimbursement negotiations, and utilization.

Masters, Health Management, 3.83

Bachelors, Marketing

Semester abroad in London, England.